TerminatedPhase 3

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Stopped: Company decision

United States23 participantsStarted 2022-06-28

Plain-language summary

The purpose of this study is to evaluate the safety and efficacy of LB1148 in subjects undergoing planned bowel resection.

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Adults age 18 to 80 years, inclusive.
✓. Scheduled to undergo a planned (non-emergent) bowel resection via minimally invasive technique or laparotomy. This includes any subject in which a resection of the small intestine, colon, or rectum is performed for any elective indication.
✓. Willing to perform and comply with all study procedures including, being hospitalized until achieving GI-2 and responding to telephone follow-up visits as scheduled.
✓. Willing and able to provide written informed consent.

Time to Return of Gastrointestinal Function

Timeframe: From surgical procedure up to 14 days in hospital

NCT IDNCT05470387

SponsorPalisade Bio

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-03-06

Results submitted2024-04-01